Tag Archives: NASDAQ:AFFY

Quick News Overview of Healthcare Sector: Allscripts Healthcare (NASDAQ:MDRX), Dendreon (NASDAQ:DNDN) – MDRX, DNDN, CLSN, AFFY, DNDN, DCTH

Posted on May 10, 2013 by Thomas Vedder

Healthcare sector finished negatively on Thursday’s trading session and sector moved down -0.12%. If we consider key percentage decliners of this sector so Affymax, Inc (NASDAQ:AFFY) was major percentage gainer while key percentage decliners were Dendreon Corporation (NASDAQ:DNDN) and Delcath …

Posted in Healthcare, Latest Headlines | Tagged AFFY, Affymax, Allscripts Healthcare, Celsion, CLSN, DCTH, Delcath, Dendreon, DNDN, MDRX, NASDAQ:AFFY, NASDAQ:CLSN, NASDAQ:DCTH, NASDAQ:DNDN, NASDAQ:MDRX | Comments Off

Zep Inc.’s (NYSE:ZEP) Logs Healthy Quarter, Affymetrix Inc. (NASDAQ:AFFX) Predicts Dreary Outlook

Posted on April 9, 2013 by Geoff Noir

Zep Inc.’s (NYSE:ZEP) reported that its second-quarter earnings climbed up 15% as the commercial cleaning-products firm announced robust revenue and margins.

For the quarter concluded on Feb. 28, Zep (ZEP) declared a profit of $2.8 million, or 12 cents per …

Posted in Latest Headlines | Tagged AFFY, Affymax, NASDAQ:AFFY, NYSE:ZEP, ZEP | Comments Off

Affymax Inc. (NASDAQ:AFFY) Shares Down after Restructuring call on Tuesday

Posted on March 19, 2013 by Geoff Noir

On Tuesday, Affymax Inc. (NASDAQ:AFFY) shares plunged 55% in premarket session, as the company declared on Monday that it would lower over 200 jobs or 75% of its labor force, along with ousting of its chief commercial officer, to reform, …

Posted in Latest Headlines | Tagged AFFY, Affymax, NASDAQ:AFFY, NYSE:UBS, UBS | Comments Off

McDonald’s Corp. (NYSE:MCD) Cheers Investors with Rosy Monthly Same Store Sales Figure

Posted on March 8, 2013 by Thomas Vedder

McDonald’s Corp. (NYSE:MCD) reported on Friday that its global same store sales in the month of February plunged 1.5% as the year-earlier quarter had one extra day due to leap year.

Omitting the inconsistency, global comparable sales jumped up 1.7% …

Posted in Latest Headlines | Tagged AFFY, Affymax, MCD, McDonald's, NASDAQ:AFFY, NYSE:MCD | Comments Off

Healthcare Sector Quick Roundup: Medifast (NYSE:MED), Pfizer Inc (NYSE:PFE) – MED, PFE, JNJ, AFFY, PGNX, POZN

Posted on March 8, 2013 by Thomas Vedder

Healthcare sector reacted positively on Thursday’s trading session and sector hiked slightly. If we look at key movers of the sector so Affymax, Inc (NASDAQ:AFFY) and Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) were major percentage on percentage gainer side while key decliner …

Posted in Healthcare, Latest Headlines | Tagged AFFY, Affymax, JNJ, Johnson, MED, Medifast, NASDAQ:AFFY, NASDAQ:PGNX, NASDAQ:POZN, NYSE:JNJ, NYSE:MED, NYSE:PFE, PFE, Pfizer, PGNX, Pozen, POZN, Progenics Pharmaceuticals | Comments Off

Healthcare Stocks Roundup; Pfizer (NYSE:PFE) Lifts Dividend while Tranzyme (TZYM) Ends Phase 2B Trail of Gastroparesis – PFE, TZYM, GSK, VVUS, ONCY, AFFY

Posted on December 18, 2012 by Thomas Vedder

On Monday, investors responded positively to the healthcare stocks. Key movement were observed in VIVUS, Inc (NASDAQ:VVUS) and Oncolytics Biotech, Inc (USA) (NASDAQ:ONCY) on percentage gainers side while Affymax, Inc (NASDAQ:AFFY) was prominent stock on the decliners side.

Pfizer Inc …

Posted in Healthcare, Latest Headlines | Tagged AFFY, Affymax, GlaxoSmithKline, GSK, NASDAQ:AFFY, NASDAQ:ONCY, NASDAQ:TZYM, NASDAQ:VVUS, NYSE:GSK, NYSE:PFE, Oncolytics Biotech, ONCY, PFE, Pfizer, Tranzyme, TZYM, Vivus, VVUS | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.